The FDA has approved new options for the treatment of melanoma lesions, soft tissue sarcomas, and the rare metabolic disease, hypophosphatasia, that clinicians should be aware of.
Recent research has identified a molecular pathway associated with cancer-related muscle weakness, a discovery which could help to improved muscle function in patients.
Researchers conducted an international, multicenter, randomized noninferiority trial comparing radical hysterectomy with simple hysterectomy, including lymph-node assessment, in patients with low-risk...
A pilot randomized trial found that digital health coaching led to numerical, though not statistically significant, improvements in self-efficacy among patients with newly diagnosed acute myeloid leukemia....
